[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":11373000.0,"TreasuryStockValue_0_Q2_USD":149329000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":16813000.0,"EarningsPerShareDiluted_1_Q2_USD":4.68,"EarningsPerShareDiluted_2_Q2_USD":9.47,"AccountsReceivableNet_0_Q2_USD":22441000.0,"StockIssuedDuringPeriodValueOther_2_Q2_USD":-17037000.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":-7792000.0,"SellingExpense_2_Q2_USD":3773000.0,"SellingExpense_1_Q2_USD":1703000.0,"InvestmentIncomeInterest_2_Q2_USD":858000.0,"InvestmentIncomeInterest_1_Q2_USD":367000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":503000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":21945000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":10767000.0,"FinitelivedIntangibleAssetsAcquired1_2_Q2_USD":13840000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1844.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1835.0,"OtherAssetsNoncurrent_0_Q2_USD":2257000.0,"NonoperatingIncomeExpense_2_Q2_USD":185000.0,"NonoperatingIncomeExpense_1_Q2_USD":721000.0,"IncreaseDecreaseInAccruedTaxesPayable_2_Q2_USD":3651000.0,"Goodwill_0_Q2_USD":9730000.0,"EarningsPerShareBasic_1_Q2_USD":4.69,"EarningsPerShareBasic_2_Q2_USD":9.49,"CostOfGoodsAndServicesSold_2_Q2_USD":44226000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":20499000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":22000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":4000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":207814000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":5000.0,"Dividends_1_Q2_USD":-2844000.0,"SaleOfStockConsiderationReceivedOnTransaction_1_Q2_USD":-55000.0,"SaleOfStockConsiderationReceivedOnTransaction_2_Q2_USD":-55000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":20774000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":55000.0,"OtherShortTermInvestments_0_Q2_USD":6573000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":-66000.0,"OtherLongTermInvestments_0_Q2_USD":56872000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":9972000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":19020000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-2000000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-254000.0,"HeldToMaturitySecurities_0_Q2_USD":56233000.0,"GainLossOnSaleOfOtherInvestments_2_Q2_USD":-673000.0,"GainLossOnSaleOfOtherInvestments_1_Q2_USD":354000.0,"DebtSecuritiesHeldToMaturityAllowanceForCreditLoss_0_Q2_USD":82000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":3.1,"CommonStockDividendsPerShareDeclared_1_Q2_USD":1.55,"LineOfCredit_0_Q2_USD":0.0,"LongTermInvestments_0_Q2_USD":56871000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":11380000.0,"ProceedsFromSaleOfEquityMethodInvestments_2_Q2_USD":896000.0,"FiniteLivedPatentsGross_0_Q2_USD":1480000.0,"StockGrantedDuringPeriodValueSharebasedCompensation_2_Q2_USD":1000000.0,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q2_USD":616000.0,"ShortTermInvestments_0_Q2_USD":6574000.0,"PaymentsToAcquireInvestments_2_Q2_USD":30444000.0,"PaymentsOfDividends_2_Q2_USD":5706000.0,"Dividends_2_Q2_USD":-5717000.0,"TreasuryStockCommonShares_0_Q2_shares":1591000.0,"OtherAssets_0_Q2_USD":13467000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-681000.0,"NetIncomeLoss_1_Q2_USD":8605000.0,"NetIncomeLoss_2_Q2_USD":17502000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":19423000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-17574000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-22798000.0,"LiabilitiesCurrent_0_Q2_USD":15443000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":260350000.0,"InventoryNet_0_Q2_USD":45805000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3558000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-4443000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-2162000.0,"GrossProfit_2_Q2_USD":37337000.0,"GrossProfit_1_Q2_USD":17469000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9028000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4628000.0,"CostOfRevenue_2_Q2_USD":81563000.0,"CostOfRevenue_1_Q2_USD":37968000.0,"CommonStockValue_0_Q2_USD":342000.0,"CommonStockSharesIssued_0_Q2_shares":3420.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-20949000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":24099000.0,"AssetsCurrent_0_Q2_USD":102145000.0,"Assets_0_Q2_USD":260350000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":12000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":8.0,"AdditionalPaidInCapital_0_Q2_USD":53020000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":4070000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":8800000.0,"InventoryGross_0_Q2_USD":45805000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3226000.0,"ProfitLoss_2_Q2_USD":17502000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-3712000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":518000.0,"IncomeTaxesPaid_2_Q2_USD":199000.0,"Cash_0_Q2_USD":24099000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":60000000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":30000000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_Q2_USD":25459000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":119947000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1849.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1839.0,"ShareBasedCompensation_2_Q2_USD":991000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":2776000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":1092000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":17037000.0,"OperatingIncomeLoss_2_Q2_USD":21760000.0,"OperatingIncomeLoss_1_Q2_USD":10046000.0,"OperatingExpenses_2_Q2_USD":15577000.0,"OperatingExpenses_1_Q2_USD":7423000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":12360000.0,"DepreciationAndAmortization_2_Q2_USD":5574000.0,"CommonStockSharesAuthorized_0_Q2_shares":10000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.1,"StockholdersEquity_0_Q2_USD":233527000.0,"Revenues_2_Q2_USD":81563000.0,"Revenues_1_Q2_USD":37968000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":329494000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":87867000.0,"ProfitLoss_1_Q2_USD":8605000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":933000.0,"Ticker":"ATRI","CIK":"701288","name":"ATRION CORP","OfficialName":"Atrion Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1317175511.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]